Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth K W To

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Molecular Cancer Research : MCR|March 2, 2011
Upregulation of ABCG2 by romidepsin via the aryl hydrocarbon receptor pathwayKenneth K W To, Robert Robey, Zhirong Zhan, et al.
Cell Cycle (Georgetown, Tex.)|August 3, 2007
Hypoxic suppression of the cell cycle gene CDC25A in tumor cellsStefanie Hammer, Kenneth K-W To, Young-Gun Yoo, et al.
Frontiers in Oncology|July 3, 2018
Recent Advances in the Treatment of Breast CancerChristy W S Tong, Mingxia Wu, William C S Cho, et al.
Molecular Cancer|January 28, 2025
Correction: Intra-tumoral sphingobacterium multivorum promotes triple-negative breast cancer progression by suppressing tumor immunosurveillanceZhikai Mai, Liwu Fu, Jiyan Su, et al.
Molecular Cancer|January 8, 2025
Intra-tumoral sphingobacterium multivorum promotes triple-negative breast cancer progression by suppressing tumor immunosurveillanceZhikai Mai, Liwu Fu, Jiyan Su, et al.
Life Sciences|August 10, 2020
Flavonoids potentiated anticancer activity of cisplatin in non-small cell lung cancer cells in vitro by inhibiting histone deacetylasesWei Yan, Tracy H Y Wu, Sharon S Y Leung, et al.
Molecular Cancer Research : MCR|February 1, 2008
Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cellsKenneth K W To, Orsolya Polgar, Lyn M Huff, et al.
Biomaterials Science|November 8, 2023
A thermosensitive hydrogel formulation of phage and colistin combination for the management of multidrug-resistant <i>Acinetobacter baumannii</i> wound infectionsSubhankar Mukhopadhyay, Kenneth K W To, Yannan Liu, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 16, 2025
Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapyYan Yang, Sijia Li, Kenneth K W To, et al.
Peptides|January 1, 2013
Reversal of ABCG2-mediated multidrug resistance by human cathelicidin and its analogs in cancer cellsKenneth K W To, S X Ren, C C M Wong, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Molecular Cancer Research : MCR|March 2, 2011
Upregulation of ABCG2 by romidepsin via the aryl hydrocarbon receptor pathwayKenneth K W To, Robert Robey, Zhirong Zhan, et al.
Cell Cycle (Georgetown, Tex.)|August 3, 2007
Hypoxic suppression of the cell cycle gene CDC25A in tumor cellsStefanie Hammer, Kenneth K-W To, Young-Gun Yoo, et al.
Frontiers in Oncology|July 3, 2018
Recent Advances in the Treatment of Breast CancerChristy W S Tong, Mingxia Wu, William C S Cho, et al.
Molecular Cancer|January 28, 2025
Correction: Intra-tumoral sphingobacterium multivorum promotes triple-negative breast cancer progression by suppressing tumor immunosurveillanceZhikai Mai, Liwu Fu, Jiyan Su, et al.
Molecular Cancer|January 8, 2025
Intra-tumoral sphingobacterium multivorum promotes triple-negative breast cancer progression by suppressing tumor immunosurveillanceZhikai Mai, Liwu Fu, Jiyan Su, et al.
Life Sciences|August 10, 2020
Flavonoids potentiated anticancer activity of cisplatin in non-small cell lung cancer cells in vitro by inhibiting histone deacetylasesWei Yan, Tracy H Y Wu, Sharon S Y Leung, et al.
Molecular Cancer Research : MCR|February 1, 2008
Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cellsKenneth K W To, Orsolya Polgar, Lyn M Huff, et al.
Biomaterials Science|November 8, 2023
A thermosensitive hydrogel formulation of phage and colistin combination for the management of multidrug-resistant <i>Acinetobacter baumannii</i> wound infectionsSubhankar Mukhopadhyay, Kenneth K W To, Yannan Liu, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 16, 2025
Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapyYan Yang, Sijia Li, Kenneth K W To, et al.
Peptides|January 1, 2013
Reversal of ABCG2-mediated multidrug resistance by human cathelicidin and its analogs in cancer cellsKenneth K W To, S X Ren, C C M Wong, et al.
Pageof 10